130 related articles for article (PubMed ID: 7993574)
1. Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy.
Kraat YJ; Christiaans MH; Nieman FH; van den Berg-Loonen PM; van Hooff JP; Bruggeman CA
Transpl Int; 1994 Aug; 7(5):362-7. PubMed ID: 7993574
[TBL] [Abstract][Full Text] [Related]
2. [Factors influencing prevalence and clinical course of cytomegalovirus (CMV) infection in kidney transplant patients].
Szymczakiewicz-Multanowska AM; Kuźniewski M; Zawilińska B; Zgórniak-Nowosielska I; Uracz D; Ignacak E; Betkowska-Prokop A; Sułowicz W
Przegl Lek; 2001; 58(7-8):772-7. PubMed ID: 11769385
[TBL] [Abstract][Full Text] [Related]
3. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of CMV infection in HLA-DR7 matched renal allograft recipients.
Kraat YJ; Christiaans MH; Nieman FH; van den Berg-Loonen PM; van Hooff JP; Bruggeman CA
Lancet; 1993 Feb; 341(8843):494-5. PubMed ID: 8094513
[No Abstract] [Full Text] [Related]
5. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.
Lee YM; Kim YH; Han DJ; Park SK; Park JS; Sung H; Hong HL; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO
Transpl Infect Dis; 2014 Jun; 16(3):397-402. PubMed ID: 24810355
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
8. The influence of HLA A-B-DR matching on cytomegalovirus disease after renal transplantation. Evidence that HLA-DR7-matched recipients are more susceptible to cytomegalovirus disease.
Blancho G; Josien R; Douillard D; Bignon JD; Cesbron A; Soulillou JP
Transplantation; 1992 Nov; 54(5):871-4. PubMed ID: 1332224
[TBL] [Abstract][Full Text] [Related]
9. Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.
Huurman VA; Kalpoe JS; van de Linde P; Vaessen N; Ringers J; Kroes AC; Roep BO; De Fijter JW
Diabetes Care; 2006 Apr; 29(4):842-7. PubMed ID: 16567825
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection in renal transplant recipients.
Carstens J; Andersen HK; Spencer E; Madsen M
Transpl Infect Dis; 2006 Dec; 8(4):203-12. PubMed ID: 17116133
[TBL] [Abstract][Full Text] [Related]
11. A comparison of triple-therapy with double-therapy immunosuppression in cadaveric renal transplantation.
Bowman JS; Angstadt JD; Waymack JP; Jaffers GJ
Transplantation; 1992 Mar; 53(3):556-9. PubMed ID: 1312752
[TBL] [Abstract][Full Text] [Related]
12. Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat.
Lautenschlager I; Soots A; Krogerus L; Kauppinen H; Saarinen O; Bruggeman C; Ahonen J
Transplantation; 1997 Aug; 64(3):391-8. PubMed ID: 9275101
[TBL] [Abstract][Full Text] [Related]
13. HLA mismatching and cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal allograft recipients.
Morris DJ; Martin S; Dyer PA; Hunt L; Mallick NP; Johnson RW
J Med Virol; 1993 Dec; 41(4):324-7. PubMed ID: 8106868
[TBL] [Abstract][Full Text] [Related]
14. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
15. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
Michelo CM; van der Meer A; Tijssen HJ; Zomer R; Stelma F; Hilbrands LB; Joosten I
Transplantation; 2015 Jul; 99(7):1506-13. PubMed ID: 25427165
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors.
Taherimahmoudi M; Ahmadi H; Baradaran N; Montaser-Kouhsari L; Salem S; Mehrsai A; Kalantar E; Jahani Y; Pourmand G
Transplant Proc; 2009 Sep; 41(7):2841-4. PubMed ID: 19765452
[TBL] [Abstract][Full Text] [Related]
17. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
[TBL] [Abstract][Full Text] [Related]
18. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients.
Sagedal S; Nordal KP; Hartmann A; Sund S; Scott H; Degré M; Foss A; Leivestad T; Osnes K; Fauchald P; Rollag H
Am J Transplant; 2002 Oct; 2(9):850-6. PubMed ID: 12392291
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.
Bataille S; Moal V; Gaudart J; Indreies M; Purgus R; Dussol B; Zandotti C; Berland Y; Vacher-Coponat H
Transpl Infect Dis; 2010 Dec; 12(6):480-8. PubMed ID: 20629971
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection renal transplant recipients: risk factors and outcome.
Kanter J; Pallardó L; Gavela E; Escudero V; Beltrán S; Morales A; Avila A; Crespo JF
Transplant Proc; 2009; 41(6):2156-8. PubMed ID: 19715860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
